Your browser doesn't support javascript.
loading
The efficacy and safety of combined GLP-1RA and basal insulin therapy among inadequately controlled T2D with premixed insulin therapy.
Liu, Jhih-Syuan; Su, Sheng-Chiang; Kuo, Feng-Chih; Li, Peng-Fei; Huang, Chia-Luen; Ho, Li-Ju; Chen, Kuan-Chan; Liu, Yi-Chen; Lin, Chih-Ping; Cheng, An-Che; Lee, Chien-Hsing; Lin, Fu-Huang; Hung, Yi-Jen; Liu, Hsin-Ya; Lu, Chieh-Hua; Hsieh, Chang-Hsun.
Afiliación
  • Liu JS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Su SC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Kuo FC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Li PF; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Huang CL; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Ho LJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Chen KC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Liu YC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Lin CP; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Cheng AC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Lee CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Lin FH; School of Public Health, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Hung YJ; Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Liu HY; BeYoung Research Institute.
  • Lu CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
  • Hsieh CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Medicine (Baltimore) ; 102(10): e33167, 2023 Mar 10.
Article en En | MEDLINE | ID: mdl-36897731
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insulina Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Medicine (Baltimore) Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insulina Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Medicine (Baltimore) Año: 2023 Tipo del documento: Article